Cargando…
Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment
The search for therapeutic targets for Parkinson’s disease (PD) is hindered by the incomplete understanding of the pathophysiology of the disease. Mitochondrial dysfunction is an area with high potential. The neurobiological signaling connections between the gut microbiome and the central nervous sy...
Autores principales: | Liang, Yixuan, Cui, Li, Gao, Jiguo, Zhu, Mingqin, Zhang, Ying, Zhang, Hong-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280023/ https://www.ncbi.nlm.nih.gov/pubmed/33825149 http://dx.doi.org/10.1007/s12035-021-02375-0 |
Ejemplares similares
-
Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment
por: Liu, Shan, et al.
Publicado: (2020) -
Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010) -
Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022) -
Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications
por: Zheng, Wei, et al.
Publicado: (2022) -
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)